Michelle Robertson - Jan 10, 2023 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF FINANCIAL OFFICER
Signature
/s/ Michelle Robertson
Stock symbol
EDIT
Transactions as of
Jan 10, 2023
Transactions value $
-$14,296
Form type
4
Date filed
1/12/2023, 03:30 PM
Previous filing
Dec 6, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale -$14.3K -1.75K -2.13% $8.16 80.5K Jan 10, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30,2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 9,2023. The sale does not represent a discretionary trade by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $8.1600 to $8.1911. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.